PLPablo Lamelas

Pablo Lamelas

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Pablo Lamelas has a total of 322 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Persisting Sex Discrepancies in Short-Term Outcomes of Patients with ST-Segment Myocardial Infarction: Results of the ISACS-STEMI COVID-19 Registry

    by Giuseppe De Luca, Stephane Manzo-Silberman, Filippo Zilio, Magdy Algowhary, Berat Uguz, Dinaldo C. Oliveira, Vladimir Ganyukov, Zan Zimbakov, Miha Cercek, Lisette Okkels Jensen, et al.

    Background. Despite technological innovations and improvements in stents and devices, sex-related discrepancies are still reported in the outcomes after ST-segment elevation myocardial infarction (STEMI), depending on biological and sex-specific pathophysiological differences, which have not been completely understood. The aim of the present study was to provide real-world data on the prognostic role of sex among patients with STEMI, enclosed into a recent up-to-date international registry. Methods. The ISACS-STEMI COVID-19 is a large-scale retrospective registry, including STEMI patients treated with mechanical reperfusion between 1 March and 30 June, 2019 and 2020. Patients, treated in 109 centers across Europe, Latin America, Southeast Asia, and North Africa, were grouped according to sex. Primary endpoint: In-hospital mortality; secondary endpoints: Time delay, 30-day mortality, and postprocedural Thrombolysis In Myocardial Infarction (TIMI) 3 flow. Results. We included 16,083 patients, 24.3% females (54.3% hospitalized in 2019, 45.7% in 2020). Women with STEMI were older, more often diabetic and hypertensive (p < 0.001), with a higher prevalence of hypercholesterolemia (p = 0.02), longer ischemia time (p = 0.01), ambulance referral (p = 0.03) and cardiogenic shock at presentation (p = 0.05), but less frequently smokers, with a previous cardiovascular event (p < 0.001) or anterior STEMI (p = 0.03) as compared to males. Preprocedural TIMI 0 flow, multivessel disease, need for thrombectomy (p < 0.001 and p = 0.001, respectively), use of Glycoprotein IIbIIIa inhibitors or cangrelor, radial access and implantation of drug-eluting stents (p < 0.001, p < 0.001 and p = 0.001, respectively) were also more common in men. Impaired postprocedural epicardial reperfusion (TIMI flow 0–2) was observed more frequently in females as compared to males (10% vs. 7.2%; adjusted OR [95% CI] = 1.30 [1.13–1.49], p = 0.01). In-hospital mortality was 5.8%, significantly higher among women (8.3% vs. 5%, p < 0.001, adjusted HR [95% CI] = 1.26 [1.06–1.5], p = 0.01). Similar data were observed for 30-day mortality (10.3% vs. 6.2%, p < 0.001, adjusted HR [95% CI] = 1.22 [1.06–1.38], p = 0.007). Conclusions. Among STEMI patients being treated with the most updated standard of care for primary percutaneous coronary intervention, female sex is still associated with higher complexity and impaired prognosis, displaying suboptimal epicardial reperfusion and increased in-hospital and 30-day mortality.


  • Predictors of permanent pacemaker implantation for transcatheter self‐expandable aortic valve implant in the cusp overlap era

    by Oscar A. Mendiz, Carlos Fava, Lucas I. Müller, Gustavo A. Lev, Gaston Heredia, Silvina E. Gómez, Joaquín Cedeño, Juan M. Pérez, Pablo Lamelas

    Background: Predictors of permanent pacemaker implantation (PPMI) after self‐expanding transcatheter aortic valve implant (TAVI) were described. Is unknown if PPMI predictors remain in the era of high implants using the cusp overlap (COP).Methods: Single‐center, prospective, consecutive case series of patients undergoing self‐expanding TAVI with the COP approach. The status of PPMI and other clinical events were ascertained at 30 days.Results: A total of 261 patients were included (84% with Evolut, n = 219). Implant depth >4 mm was infrequent (13.8%). TAVI depth (OR 1.259; p = 0.005), first or second‐degree auriculo‐ventricular block (OR 3.406; p = 0.033), right‐bundle (OR 15.477; p < 0.0001), and incomplete left‐bundle branch block (OR 7.964; p = 0.036) were found to be independent predictors of PPMI. The risk of PPMI with deep implant and no electrical disturbances was 3%, and 0% with high implant and no prior electrical disturbances. Those who received PPMI had no statistically significant increased risk of death, myocardial infarction, stroke, bleeding events, or vascular complications at 30 days, but longer hospital stay (mean difference 1.43 days more, p = 0.003).Conclusions: Implant depth and prior conduction abnormalities remain the main predictors of PPMI using self‐expanding TAVI in the COP era. Patients with high implants and no prior conduction abnormalities may be candidates for early discharge after uneventful self‐expanding TAVI, while the rest may need inpatient monitoring regardless of achieving a high implant. The need for PPMI was associated with longer hospital stays.


  • Open Access

    Impacto de un modelo asistencial específicamente diseñado en el programa de angioplastia coronaria ambulatoria

    by Federico Liberman, Fernando O. Botto, Mariano N. Benzadon, Pablo M. Lamelas, Pablo M. Spaletra, Gustavo O. Pedernera, Santiago Ordoñez, Lucio T. Padilla, Jorge Belardi, Fernando A. Cura

    Background: An outpatient model of care for percutaneous coronary procedures called Radial Lounge (RL) was designed at our center. Patients wear their own clothes throughout their stay, with no mobility restrictions and without fasting. Before and after the procedure, they remain in an armchair accompanied by a family member until discharge, without continuous monitoring, under the supervision of a nurse dedicated exclusively to this area. Objectives: The aim of this study was to evaluate the safety and efficacy of the RL model of care, the same-day discharge (SDD) rate, patient experience, and major adverse cardiovascular events (MACE): in-hospital mortality, overall mortality, and re-hospitalization at 30 days Methods: A retrospective observational cohort study was conducted at a cardiovascular center, including consecutively enrolled patients undergoing elective percutaneous coronary intervention (PCI) in the RL. Results: A total of 2102 elective PCI procedures were included under the RL model. The SDD rate was 85.3% in the first year of its implementation (2018) and reached 89% in 2022. Assessing patient experience, the average score obtained through the Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey was 9.61/10. The rate of MACE was not higher than that reported in the literature. Conclusion: The PCI program in the RL proved to be a safe and effective model in our experience. How to cite this article: Liberman F, Botto FO, Benzadón MN, Lamelas PM, Spaletra PM, Pedernera GO, y cols. Impact of a Specifically Designed Model of Care in an Outpatient Coronary Angioplasty Program. Rev Argent Cardiol 2024;92:183-8. http://dx.doi.org/10.7775/rac.v92.i3.20770

  • Impact of a Specifically Designed Model of Care in an Outpatient Coronary Angioplasty Program

    by Federico Liberman, Fernando O. Botto, Mariano N. Benzadon, Pablo M. Lamelas, Pablo M. Spaletra, Gustavo O. Pedernera, Santiago Ordoñez, Lucio T. Padilla, Jorge Belardi, Fernando A. Cura

    Background: An outpatient model of care for percutaneous coronary procedures called Radial Lounge (RL) was designed at our center. Patients wear their own clothes throughout their stay, with no mobility restrictions and without fasting. Before and after the procedure, they remain in an armchair accompanied by a family member until discharge, without continuous monitoring, under the supervision of a nurse dedicated exclusively to this area. Objectives: The aim of this study was to evaluate the safety and efficacy of the RL model of care, the same-day discharge (SDD) rate, patient experience, and major adverse cardiovascular events (MACE): in-hospital mortality, overall mortality, and re-hospitalization at 30 days Methods: A retrospective observational cohort study was conducted at a cardiovascular center, including consecutively enrolled patients undergoing elective percutaneous coronary intervention (PCI) in the RL. Results: A total of 2102 elective PCI procedures were included under the RL model. The SDD rate was 85.3% in the first year of its implementation (2018) and reached 89% in 2022. Assessing patient experience, the average score obtained through the Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey was 9.61/10. The rate of MACE was not higher than that reported in the literature. Conclusion: The PCI program in the RL proved to be a safe and effective model in our experience.

  • Open Access

    Herramientas para la toma de decisiones en pacientes con enfermedad de múltiples vasos

    by Julián Feder, Ana Lía Gamarra, Diego Conde, Alan Sigal, Juan Furmento, Pablo Lamelas, Ian Chapman, Mariano Vrancic, Marcelo Trivi, Juan Pablo Costabel

    The decision on the best revascularization strategy for patients with multivessel disease has become a complex task as coronary angioplasty has improved its results. In the following review, we set out to evaluate the variables that, in our experience, define the benefit of one technique over the other, understanding that in this way the treating physician's decision will become simpler and more objective. On the other hand, and celebrating the healthy prominence given to patients, we believe that this evaluation allows solid arguments to help them in decision making. Key words: Percutaneous Coronary Angioplasty - Coronary Artery Bypass Graft - Multiple Vessels Disease How to cite this article Feder J, Gamarra AL, Conde D, Sigal A, Furmento J, Lamelas P, et al. Tools for Decision Making in Patients with Multivessel Disease. Rev Argent Cardiol 2023;91:349-56. http://dx.doi.org/10.7775/rac.v91.i5.20670

  • Open Access

    Impacto de un Heart Team en pacientes con estenosis aórtica candidatos a reemplazo percutáneo.

    by Marcelo Trivi, María F. Castro, Romina Trossero, Fernando A. Cura, Fernando Piccinini, Alfonsina Candiello, Pablo Lamelas, Ruth Henquin, Fernando Botto, Ricardo Ronderos

    As transcatheter aortic valve implantation (TAVI) for aortic stenosis (AS) became widespread, there arose the need for a Heart Team (HT) to choose the best treatment. There are few reports as regards its usefulness. Objectives: To analyze treatment outcomes in patients with AS evaluated by a HT for 10 years. Methods: Consecutive enrollment of all patients with AS who were candidates for TAVI between January 2012 and July 2021 to choose the best treatment, including surgical aortic valve replacement (SAVR) and conservative medical management (CMM). Results: Out of 841 patients, 455 were assigned to TAVI (53%), 213 to SAVR (24%), and 183 to CMM (23%). The percentage assigned to TAVI has increased from 48% to 62% over time (p <0.05). Patients who underwent TAVI versus those who underwent SAVR were older (86 ± 7 vs. 83 ± 7 years), had a higher EUROSCORE II (6.2, 95% CI 5.7-6.6 vs. 5.6; 95% CI 4.4-6.5) and were frailer (1.62 ± 1 vs. 0.91 ± 1) in all cases (p <0.01). Actuarial survival (95% CI) at 1 and 2 years was 88% (84-91%) and 82% (77-86%) for TAVI, 83% (76-88%) and 78% (70-84%) for SAVR, and 70% (60-87%) and 59% (48-68%) for CMM, respectively (p <0.001). Conclusions: For the first 10 years after a Heart Team was established for AS decision-making, approximately half of the patients were assigned to TAVI, and the rest were equally assigned in halves to either surgery or observation. Survival for patients who received interventions was similar at 2 years and higher than in those who did not. How to cite this article: Trivi MS, Castro MF, Trossero R, Cura FA, Piccinini FF, Candiello F, y cols. Impact of a Heart Team in patients with aortic stenosis who are candidates for transcatheter aortic valve replacement. Rev Argent Cardiol 2023;91:246-51. http://dx.doi.org/10.7775/rac.v91.i4.20649

  • Open Access

    Impacto de un Heart Team en pacientes con estenosis aórtica candidatos a reemplazo percutáneo.

    by Marcelo Trivi, María F. Castro, Romina Trossero, Fernando A. Cura, Fernando Piccinini, Alfonsina Candiello, Pablo Lamelas, Ruth Henquin, Fernando Botto, Ricardo Ronderos

    As transcatheter aortic valve implantation (TAVI) for aortic stenosis (AS) became widespread, there arose the need for a Heart Team (HT) to choose the best treatment. There are few reports as regards its usefulness. Objectives: To analyze treatment outcomes in patients with AS evaluated by a HT for 10 years. Methods: Consecutive enrollment of all patients with AS who were candidates for TAVI between January 2012 and July 2021 to choose the best treatment, including surgical aortic valve replacement (SAVR) and conservative medical management (CMM). Results: Out of 841 patients, 455 were assigned to TAVI (53%), 213 to SAVR (24%), and 183 to CMM (23%). The percentage assigned to TAVI has increased from 48% to 62% over time (p <0.05). Patients who underwent TAVI versus those who underwent SAVR were older (86 ± 7 vs. 83 ± 7 years), had a higher EUROSCORE II (6.2, 95% CI 5.7-6.6 vs. 5.6; 95% CI 4.4-6.5) and were frailer (1.62 ± 1 vs. 0.91 ± 1) in all cases (p <0.01). Actuarial survival (95% CI) at 1 and 2 years was 88% (84-91%) and 82% (77-86%) for TAVI, 83% (76-88%) and 78% (70-84%) for SAVR, and 70% (60-87%) and 59% (48-68%) for CMM, respectively (p <0.001). Conclusions: For the first 10 years after a Heart Team was established for AS decision-making, approximately half of the patients were assigned to TAVI, and the rest were equally assigned in halves to either surgery or observation. Survival for patients who received interventions was similar at 2 years and higher than in those who did not. How to cite this article: Trivi MS, Castro MF, Trossero R, Cura FA, Piccinini FF, Candiello F, y cols. Impact of a Heart Team in patients with aortic stenosis who are candidates for transcatheter aortic valve replacement. Rev Argent Cardiol 2023;91:246-51. http://dx.doi.org/10.7775/rac.v91.i4.20649

  • Impact of a Heart Team in patients with aortic stenosis who are candidates for transcatheter aortic valve replacement

    by Marcelo Trivi, María F. Castro, Romina Trossero, Fernando A. Cura, Fernando Piccinini, Alfonsina Candiello, Pablo Lamelas, Ruth Henquin, Fernando Botto, Ricardo Ronderos

    As transcatheter aortic valve implantation (TAVI) for aortic stenosis (AS) became widespread, there arose the need for a Heart Team (HT) to choose the best treatment. There are few reports as regards its usefulness. Objectives: To analyze treatment outcomes in patients with AS evaluated by a HT for 10 years. Methods: Consecutive enrollment of all patients with AS who were candidates for TAVI between January 2012 and July 2021 to choose the best treatment, including surgical aortic valve replacement (SAVR) and conservative medical management (CMM). Results: Out of 841 patients, 455 were assigned to TAVI (53%), 213 to SAVR (24%), and 183 to CMM (23%). The percentage assigned to TAVI has increased from 48% to 62% over time (p <0.05). Patients who underwent TAVI versus those who underwent SAVR were older (86 ± 7 vs. 83 ± 7 years), had a higher EUROSCORE II (6.2, 95% CI 5.7-6.6 vs. 5.6; 95% CI 4.4-6.5) and were frailer (1.62 ± 1 vs. 0.91 ± 1) in all cases (p <0.01). Actuarial survival (95% CI) at 1 and 2 years was 88% (84-91%) and 82% (77-86%) for TAVI, 83% (76-88%) and 78% (70-84%) for SAVR, and 70% (60-87%) and 59% (48-68%) for CMM, respectively (p <0.001). Conclusions: For the first 10 years after a Heart Team was established for AS decision-making, approximately half of the patients were assigned to TAVI, and the rest were equally assigned in halves to either surgery or observation. Survival for patients who received interventions was similar at 2 years and higher than in those who did not.